03 Apr, 2023 Post Hoc Analyses from ENVISION Study of GIVLAARI® (givosiran) Presented at HTRS Scientific Symposium
We presented post hoc analyses from the Phase 3 ENVISION study of givosiran in patients with acute hepatic porphyria (AHP) through Month 36 at the Hemostasis & Thrombosis Research Society (HTRS) Scientific Symposium, held on March 10-12 in Orlando, Florida.